Canada - TSX:BHC - CA0717341071 - Common Stock
ChartMill assigns a Buy % Consensus number of 49% to BHC.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-21 | Truist Securities | Maintains | Hold -> Hold |
| 2022-08-10 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-08-08 | Guggenheim Securities | Upgrade | |
| 2022-07-26 | RBC Royalbank | Downgrade | Outperform |
| 2022-05-09 | RBC Royalbank | Downgrade | Outperform |
| 2022-05-05 | Morningstar | Initiate | Buy |
| 2022-02-25 | RBC Royalbank | Downgrade | Outperform |
| 2022-02-01 | RBC Capital | Downgrade | Outperform |
| 2021-05-05 | RBC Capital | Downgrade | Outperform |
| 2021-04-30 | RBC Capital | Maintains | Outperform |
| 2021-02-25 | Barclays | Upgrade | Overweight |
| 2021-02-18 | RBC Capital | Upgrade |
9 analysts have analysed BHC.CA and the average price target is 10.2 CAD. This implies a price increase of 10.27% is expected in the next year compared to the current price of 9.25.
The consensus rating for BAUSCH HEALTH COS INC (BHC.CA) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering BAUSCH HEALTH COS INC (BHC.CA) is 9.